Phase I Trial HIPEC With Nal-irinotecan

Clinical trial NCT04088786 · COMPLETED

Trial details

NCT number: NCT04088786
Sponsor: Stony Brook University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peritoneal Cancer Pseudomyxoma Peritonei Mucinous Adenocarcinoma Mucinous Tumor Colorectal Cancer Gastric Cancer Primary Peritoneal Carcinoma Mesothelioma

Start date: 2019-10-22
Primary completion: 2021-10-11
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.